Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1975 1
1983 1
1986 2
1987 2
1988 1
1989 1
1990 1
1994 1
1995 2
1996 1
1999 2
2000 2
2001 4
2003 2
2004 1
2005 2
2006 1
2007 1
2008 1
2009 1
2011 3
2012 5
2013 4
2014 1
2015 1
2016 4
2017 1
2019 2
2020 1
2021 2
2022 5
2023 5
2024 1
2025 7
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Alirocumab Plus Cemiplimab in Immunorefractory NSCLC: A Single Arm Phase 2 Study.
Oduah E, Gray J, Stinchcombe T, Wolf S, Qin X, Ireland A, Rivera-Concepcion J, Clarke J, Crawford J, Alder L, Oswalt C, Chen A, Lyniv L, Abbasi A, Saltos A, Jung SH, Owzar K, Ready N, Oliver T, Antonia S. Oduah E, et al. Among authors: alder l. Res Sq [Preprint]. 2026 Jun 24:rs.3.rs-10011569. doi: 10.21203/rs.3.rs-10011569/v1. Res Sq. 2026. PMID: 42396524 Free PMC article. Preprint.
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.
Tarantino P, Kim SE, Hughes ME, Kusmick RJ, Smith K, Brasó-Maristany F, Nyein Chan NN, Paré Brunet L, Alder L, Garcia-Cortes D, Gomez Tejeda Zanudo J, Pereslete AM, Noteware L, Moore H, Van Swearingen AED, Li T, Gupta H, D'Amico O, Martini A, Morganti S, Spindel J, Cook C, McLaughlin C, Dvir K, Garrido-Castro AC, Sammons S, Files J, Sendrick K, Buck S, Dillon D, Jeselsohn R, Li YY, Cherniack AD, LoRusso P, Lustberg M, Vega-León R, Pardo F, Davis J, Mueller C, Corgiat B, Curigliano G, Anders CK, Petricoin EF, Rimm DL, Prat A, Tayob N, Lin NU, Tolaney SM. Tarantino P, et al. Among authors: alder l. NPJ Precis Oncol. 2026 Mar 13;10(1):141. doi: 10.1038/s41698-026-01365-6. NPJ Precis Oncol. 2026. PMID: 41826432 Free PMC article.
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasis.
Qazi JJ, Van Swearingen AED, Carpenter DJ, Broadwater G, Leng JX, Arshad M, Chmura SJ, Bansal R, Alder L, Fecci PE, Kirkpatrick JP, Salama JK, Mullikin TC, Floyd SR, Anders CK. Qazi JJ, et al. Among authors: alder l. Neurooncol Adv. 2025 Nov 20;7(1):vdaf214. doi: 10.1093/noajnl/vdaf214. eCollection 2025 Jan-Dec. Neurooncol Adv. 2025. PMID: 41497447 Free PMC article.
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
Zhang B, Alder L, Rosner S, Desai A, Cooper AJ, Yimer H, Bogdanska W, Naqash AR, Taylor A, Joshi U, Carlisle J, Champiat S, Altan M, Vega MF, Halm J, Manzano JG, Fenton G, Nie Y, Wang K, Parma M, Rudin CM, Chiang A, Byers LA, Gay CM, Puri S. Zhang B, et al. Among authors: alder l. Lung Cancer. 2026 Jan;211:108870. doi: 10.1016/j.lungcan.2025.108870. Epub 2025 Dec 6. Lung Cancer. 2026. PMID: 41371100
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer.
Cooper AJ, Herzberg B, Parma M, Wang K, Alder L, Weber UM, Patil T, Joshi U, Puri S, Saqi A, Clark P, Gay CM, Cascone T, Singhi EK, Blumenschein G, Skoulidis F, Tu J, Stinchcombe TE, Rudin CM, Shu CA, Byers LA, Yu H, Zhang B. Cooper AJ, et al. Among authors: alder l. JCO Precis Oncol. 2025 Oct;9:e2500538. doi: 10.1200/PO-25-00538. Epub 2025 Oct 30. JCO Precis Oncol. 2025. PMID: 41166675 Free PMC article. No abstract available.
75 results